{"name":"Spero Therapeutics","slug":"spero-therapeutics","ticker":"","exchange":"","domain":"spero.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SPR720 500 mg","genericName":"SPR720 500 mg","slug":"spr720-500-mg","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"SPR720 500 mg","genericName":"SPR720 500 mg","slug":"spr720-500-mg","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOV9xSnVBdUY5UEpyS19CQ0g3djlHZ1BIWkY5NGVYRm9FUE1vV3VvVWxoOTJqalhUZTR3bDQ3LUZhUktJa2lUTjR3aTFFUHh0U2lISjVwYjMtdl9nZXVlWmM4eWxOeHpMSU9IRk9NejZDZ2xHUmt6Q29tWmVZczJhREhjOHNiZEJ2S3RicjNpMDhOUUFCZElyZ0pwemZtUGpOOGJBZk9UOGpvZXI4ZU9LalZ1SUFqQ2oteEE1WFhEeHhGZw?oc=5","date":"2026-02-09","type":"pipeline","source":"AD HOC NEWS","summary":"The Truth About Spero Therapeutics: Is This Tiny Biotech the Next Viral Moonshot or Total Trap? - AD HOC NEWS","headline":"The Truth About Spero Therapeutics: Is This Tiny Biotech the Next Viral Moonshot or Total Trap?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQOTdBWklNdFVMNXlhZXpTamw1T2hZQk42SHhFeG5ITGkzT0pRNEFRYmRuUEdJdnloZTNBSjYyUlFYeUZsd1VUSkRLTmdaVFkzV0Rja2xQTWljSnBHME9IblZVRVpITEpoU1d4REVGYnFsVFFVUkh0QXllV1FHMkZ6LVh3clQzd3hlSFIxWjdYaVJ1Q3RLUmRrc0dqaUFhZDVUbHZ6LTVMOVNCSU9HQlhJY3RVbWhnbjA?oc=5","date":"2026-01-20","type":"pipeline","source":"Fierce Biotech","summary":"Former Spero execs fined by SEC over antibiotic efficacy claims - Fierce Biotech","headline":"Former Spero execs fined by SEC over antibiotic efficacy claims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxQUkw4dlFicFRnNlBKS3E4V1UxVnVtS2ZUb1VNNVN4TV9XM3VTUVk0ZDh2SE9vQ2xNa2pCYnJjTU9oaGhJYm9rQ0NHT0t2aHUtaWc5dUozcmVwdktCTDdKaC1oaTc0UVVSX21qeUk5M2tRVlFnZWV1clJsbXZhRFdmeFZOMHdwVE1mMDBtbktfRUt6enBfZzR4VV9KemNUakxkbF84TzZOeFJOY0xYTFMyZlpBWHFhRFIzZnZ2QkdvRXpRZ3BRekF0RV9rd3BiRVREdlF1eVdVcUhuQ0w2Q1pnT2dtYWNzWnpGQUY0ZkJVakNYSzhKMXlONll6NWg5WXZybFBrX0JDaE5iRHE5azNVdC1ZdE1ibE5XNUlaT3BUeFlncng1V1Vlb2JKUVMxLW14QTc2OW1pUW0yQlB6cnVCTUR3Z2I?oc=5","date":"2025-12-19","type":"pipeline","source":"GlobeNewswire","summary":"Spero Announces NDA Resubmission of Tebipenem HBr by GSK to - GlobeNewswire","headline":"Spero Announces NDA Resubmission of Tebipenem HBr by GSK to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2Njd3Vi1zdTdocnA1d01OZi1qVy1QQ3lYdE01N0Jfb3JsRDd3MTVJd3VjbXBESUZRaGJwVWROeEJQcUZDNzhtTDlITkpKVWQ2bnpn?oc=5","date":"2025-10-21","type":"trial","source":"FirstWord Pharma","summary":"GSK, Spero share data behind early study stop for oral antibiotic - FirstWord Pharma","headline":"GSK, Spero share data behind early study stop for oral antibiotic","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQbXY2MnNrVjFKQnp4OFJVc0VFczVHR0J2enZ1Znk4WHNLTW5iNzd0enJBWXlxLWFCWXljOXFYR0JDaW5XRnppUGpvRGVaUVI4OHN1dnJ2QXBHVV9CcWZ5S1l3WlItVFBDaHRnY0REWUNGMnBmR1ZzTXpyaC1vbGc5cVBQSXhWejlaM0dlOWtGVVJsREdOZzFSNnVxWQ?oc=5","date":"2025-10-21","type":"trial","source":"Fierce Biotech","summary":"GSK unveils positive pivotal data for Spero's once-rejected oral antibiotic - Fierce Biotech","headline":"GSK unveils positive pivotal data for Spero's once-rejected oral antibiotic","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxORDU1STg1S1VuTWZtV0YxNDJlRklDcmxIMGRBRTNwcm9YMkZYQXVFRTdoY09EaTJoTVA4WHJnd1BBcmduR1VwWVJQLVBQcWF3UzFqQ0hEQnRVN29aZTVZQVpJQ3lhLWFmYWI3djVYLVh2TmhBbzhsZ3NwbzhSRWNpZlJCX2RrajJleFE?oc=5","date":"2025-09-13","type":"pipeline","source":"TIKR.com","summary":"9 of the Fastest-Growing Biotech Stocks Under $10 Billion - TIKR.com","headline":"9 of the Fastest-Growing Biotech Stocks Under $10 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMHVXck1OOGpEbHpvVndvTm5WeEUtU1h4cTI3U25ZMWRWTU95LXVXdXVkWVJxVmpremlVSF9PYTl6QUxUSDBsSGNpWXN4Q0cxRWVwRG9GX29iTUY0U0Z0MFdMSUZXNXRua3V4LU1iR0JuZUROcTVSaTJMb1BhNWlfVlN2RUstVHNUeWRaWUZLVHlpejJLTHJlMUpGdEJCZFlRU1JzVVYwVFE?oc=5","date":"2025-05-30","type":"trial","source":"PharmTech.com","summary":"GSK, Spero Therapeutics Oral UTI Treatment Trial Stopped Early for Efficacy - PharmTech.com","headline":"GSK, Spero Therapeutics Oral UTI Treatment Trial Stopped Early for Efficacy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxORWYtMVZXcXFLNkYxNkQ5a3JpZWluaGIwS2F1SEtvNktSNVFYdzlrcU9YV1ZRXzZ1a2xWSGxKcXJSLWRrTzNUVlhTcVdIUDI3cUhTX0d6S2RseDJVWGYtSVgtc2lsY2djUlh0RXA1b1RDZ25iNHdTNUlZYXVlRFh6YWhra2ExR3JrYkotVUFHdUJra1dlYkl4NE1oczNMSWp2c3JJTVJMVWFLMHdISE5QbWdicFZXVlYyQVRjdEs2OVVmRmt5VU1iVzh2OE9oM1FlNFkyVDh3?oc=5","date":"2025-05-28","type":"trial","source":"Reuters","summary":"GSK, Spero stop UTI drug trial after early success - Reuters","headline":"GSK, Spero stop UTI drug trial after early success","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxQMU5fanVUNHNrU29SNzJvUEtVbW96YlI2UXdMcHM2QmF2LUlFSWNLek5kQVdNRC1FZkFOeTBNeDdFLWhvMnF2cXRGaU5kbTNBcGdSNTg1b1RIZ1JfUGZRSUd0YjhFWl8td1ZidVZHSlNCQjRoeWdTUkNUbFAxak8wYWdrcDQ3aVdTSm1Jd0VMUGNjc0w4UWFSQ3FFZFZCMVE4cEE2eVhWQ0JSa1M1RHQ0YjI2QUdBTEJfVTNtblR1SFkxZXZnVWdUd0lNYm1GaFU5TVhvVUNxZXpXNkhDZ1M5aDJjc2dCbmREYUt6MVZSbFZjSmxiM3F2VjN0OUs4d3R4YzN5ekNEdVpYQ0FNZXpnaWI2Z1ZCT0R0eUhSdU50VXVvZ3F0dlgwUkd6UmhyVXQ0b3IwdFdhbk9IMmNOdG1EQkxlMm55Z3FsaWRINUY3aXdSZ1E?oc=5","date":"2025-05-28","type":"trial","source":"GlobeNewswire","summary":"Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study - GlobeNewswire","headline":"Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWbTNLdWJvWDdKZ09HaExiem1GTUE1MWR3OUt6N3J2Ul93ZVhYTi1OalVEQ3NxRllfei1qckxJbjZ2VXlwZnF1R0VTVDVNSl9YeEtV?oc=5","date":"2025-05-28","type":"trial","source":"FirstWord Pharma","summary":"GSK and Spero's oral antibiotic succeeds in pivotal UTI study - FirstWord Pharma","headline":"GSK and Spero's oral antibiotic succeeds in pivotal UTI study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPVkVXTlJfT2xhcTQ2V0MycG5aUTMxWldTT255SUhJbWJXYlU3Q0h6eDlFb3UtLWxMdDFsVUc1emUySVJ2bVc1bjlaTm9nMUtHelM0b2xKZlNKeTljTENMX2g1T1ZLZlZVLVd1U3dUOE4zVjE1UVk2dWRZUm5VOUlDUXNLWktTeDcxMHZGMDZwUWFySHRTUTFCSDM4ZEZJNmM4UzZGUW9GeXRXbzVY?oc=5","date":"2025-01-19","type":"deal","source":"Seeking Alpha","summary":"Spero Therapeutics: Undervalued Based On Just Tebipenem And GSK Deal (NASDAQ:SPRO) - Seeking Alpha","headline":"Spero Therapeutics: Undervalued Based On Just Tebipenem And GSK Deal (NASDAQ:SPRO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQUFl5RjJHeVBrWkI4MlRSRi1ZUi1lUllwTFZwRnFOZWhNU1doa1pGZDItRTNKSXVnNE1WaFZMWTVyOTg2YUZQYnBpNFVIYUtDQ2U4RmVfdXk1X003UWtiYzFYcEdKellHOFJhWjVMRXZRaVlza2x4R3d0eXh2TTRRR1dDWEdrcGRKdl9ZZlZEbUROa1N3MTg0ZnVGQXFyVHhZYUZIemFCN0JVVi1QVUl1SVNWN29fYWktWl80Vno4ZkJPVFJuWDkyNWxCLXZ2UXhfSWFqdzJUTFY1ZGNOdGFBWGwxNEV5eUdrczVBcW9nTE1tMlpoanpWZGhBZkJoTkdwZ09FQmppM1dLZ2oycWdoM19XWWxXb2VnNXZjczQ4VmcyV3pIbUZhWDVaQkladw?oc=5","date":"2022-09-22","type":"pipeline","source":"GSK","summary":"GSK and Spero Therapeutics announce exclusive licence agreement for tebipenem HBr, a late-stage antibiotic that may treat complicated urinary tract infections - GSK","headline":"GSK and Spero Therapeutics announce exclusive licence agreement for tebipenem HBr, a late-stage antibiotic that may trea","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}